Oral Treatment with the Vimentin-Targeting Compound ALD-R491 Mitigates Hyperinflammation, Multi-Organ Injury, and Mortality in CLP-Induced Septic Mice口服靶向波形蛋白的化合物ALD-R491可减轻CLP诱导的败血症小鼠的高炎症反应、多器官损伤和死亡率。Life 2025, Vol. 15, Page 1563IF3.42025-10-060OAAI
Therapeutic targeting of vimentin by ALD-R491 impacts multiple pathogenic processes to attenuate acute and chronic colitis in miceBIOMEDICINE & PHARMACOTHERAPYIF7.52023-12-012OAAI
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related DiseasesMBIOIF4.72021-10-2622OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项